GSK/N 債券
以下是 GSK PLC 公司債券的清單。投資者通常選擇公司債券,因為它們在市場波動時具有更高的穩定性。研究價格、收益率和其他統計數據並找到可靠的投資。
商品 | YTM % | 成交量 | 價格 % | 票息 % | 到期日 | 未償金額 | 面值 | 最小面額金額 | 發行人 |
---|---|---|---|---|---|---|---|---|---|
XXS86659697GLAXOSMITHKL.CAP. 12/45 | 6.62% | 0 | 79.39% | 4.25% | 2045-12-18 | 370.79 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
GGX4CGLAXOSMITHKLINE CAP.13/43 | 6.12% | 0 | 83.72% | 4.20% | 2043-03-18 | 500 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
XXS217060907GLAXOSM.CAP. MTN 20/35MTN | 6.11% | 0 | 72.48% | 1.63% | 2035-05-12 | 750 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
XXS29462437GLAXOSM.CAP. MTN 07/42 | 6.09% | 0 | 93.02% | 5.25% | 2042-04-10 | 477.82 M GBP | 1,000.00 GBP | 50,000.00 GBP | GlaxoSmithKline Capital Plc |
XXS35082093GLAXOSMITHKL.CAP. 08/39 | 5.53% | 0 | 106.58% | 6.38% | 2039-03-09 | 631.3 M GBP | 1,000.00 GBP | 50,000.00 GBP | GlaxoSmithKline Capital Plc |
UUS377372AE7GLAXOSMITHKLINE CAP.2038 | 5.17% | 0 | 109.33% | 6.38% | 2038-05-15 | 2.75 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
UUS377372AQ0GLAXOSMITHKLINE CAP.25/35 | 5.14% | 0 | 98.28% | 4.88% | 2035-04-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
UUS377372AB3GLAXOSMITHKLINE CAP.04/34 | 4.96% | 0 | 102.53% | 5.38% | 2034-04-15 | 500 M USD | 1,000.00 USD | 1,000.00 USD | GlaxoSmithKline Capital, Inc. |
GGSK6023692GlaxoSmithKline Capital Plc FRN 12-MAR-2027 | 4.79% | 3 K | 100.07% | 4.84% | 2027-03-12 | 600 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
XXS14051686GLAXOSM.CAP. MTN 01/33 | 4.74% | 0 | 103.06% | 5.25% | 2033-12-19 | 574.17 M GBP | 1,000.00 GBP | 1,000.00 GBP | GlaxoSmithKline Capital Plc |
UUS377372AP2GLAXOSMITHKLINE CAP.25/30 | 4.46% | 0 | 100.16% | 4.50% | 2030-04-15 | 850 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
UUS377373AH8GLAXOSM.CAP. 19/29 | 4.45% | 0 | 96.43% | 3.38% | 2029-06-01 | 1 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
UUS377372AN7GLAXOSMITHKLINE CAP.18/28 | 4.34% | 0 | 98.83% | 3.88% | 2028-05-15 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
XXS86658852GLAXOSMITHKL.CAP. 12/27 | 4.29% | 0 | 97.99% | 3.38% | 2027-12-20 | 307.77 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
XXS217060184GLAXOSM.CAP. MTN 20/28MTN | 4.24% | 0 | 91.49% | 1.25% | 2028-10-12 | 750 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
UUS377373AM7GLAXOSM.CAP. 25/27 | 4.11% | 0 | 100.31% | 4.32% | 2027-03-12 | 400 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
XXS293369275GSK CAP B.V. 24/36 MTN | 3.57% | 0 | 97.42% | 3.25% | 2036-11-19 | 600 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
XXS255381776GSK CAP B.V. 22/32 MTN | 3.11% | 0 | 100.09% | 3.13% | 2032-11-28 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
XXS293369143GSK CAP B.V. 24/31 MTN | 3.02% | 0 | 99.25% | 2.88% | 2031-11-19 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
XXS182282979GLAXOSM.CAP. MTN 18/30MTN | 2.79% | 0 | 95.57% | 1.75% | 2030-05-21 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
XXS168152035GLAXOSM.CAP. MTN 17/29 | 2.57% | 0 | 95.50% | 1.38% | 2029-09-12 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
XXS255381768GSK CAP B.V. 22/27 MTN | 2.33% | 0 | 101.51% | 3.00% | 2027-11-28 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
GGX5BGLAXOSM.CAP. MTN 17/26 | 2.20% | 0 | 98.64% | 1.00% | 2026-09-12 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
XXS182282812GLAXOSM.CAP. MTN 18/26MTN | 2.06% | 0 | 99.32% | 1.25% | 2026-05-21 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
AAQ72GLAXOSMITHKLINE CAPITAL PLC 0.883% GTD SNR EMTN 21/09/20 | — | — | — | 0.88% | 2028-09-21 | 42.5 B JPY | 100,000,000.00 JPY | 100,000,000.00 JPY | GlaxoSmithKline Capital Plc |